Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
SAGE Open Med ; 8: 2050312120929238, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32551112

RESUMEN

INTRODUCTION: Central venous access using peripherally inserted central catheters is frequently used for patients receiving intravenous medications in the hospital or outpatients. Although there are several benefits of peripherally inserted central catheters, such as ease of insertion, low procedure-related risk and higher patient satisfaction, there are complications associated with peripherally inserted central catheter use. Despite some studies evaluating peripherally inserted central catheter line-related complications, the factors associated with peripherally inserted central catheter-related deep venous thrombosis in critically ill medical-surgical patients are poorly described. The objective of this case-control study was to identify the risk factors associated with peripherally inserted central catheter line-related deep venous thrombosis in critically ill medical-surgical intensive care unit patients in a community hospital. METHODS: We abstracted relevant clinical data from 21 cases with symptomatic peripherally inserted central catheter-related deep venous thrombosis and 42 controls with peripherally inserted central catheters but no deep venous thrombosis. RESULTS: Of the factors evaluated, female gender, the use of triple lumen peripherally inserted central catheters, larger outer diameter, and open (vs valve) peripherally inserted central catheters were associated with venous thrombosis. In this retrospective study, we did not identify any association of peripherally inserted central catheter-related deep venous thrombosis with a prior history of deep venous thrombosis, use of alteplase, antiplatelet therapy, prophylactic or therapeutic anticoagulation, international normalized ratio, platelet count and the use of peripherally inserted central catheters for total parenteral nutrition. CONCLUSION: Our study indicates that the catheter size relative to the diameter of the vein could be an important risk factor for the development of peripherally inserted central catheter-related deep venous thrombosis. The study findings should be confirmed in a larger study designed to identify risk factors of peripherally inserted central catheter-related deep venous thrombosis. In the meantime, the peripherally inserted central catheter lines should be used judiciously in critically ill patients.

2.
Poult Sci ; 96(11): 4124-4131, 2017 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-29050430

RESUMEN

Gelatin was extracted from broiler (Gallus gallus domesticus) skins and analyzed to compare its physicochemical properties with those of commercial bovine gelatin. The average yield of broiler skin gelatin was 6.5% on a wet weight basis. Broiler skin gelatin had more α1-and α2-chains than ß-chain and contained high molecular weight (γ-chain) polymers. Glycine was the dominant amino acid in broiler skin gelatin (20.26%), followed by proline (Pro) (15.12%) then hydroxyproline (Hyp) (11.36%). Compared to commercial bovine gelatin, broiler skin gelatin had less total imino acids (Pro and Hyp) but a higher (33.65 vs. 31.38°C) melting temperature (P < 0.01). The differences in physical properties between the broiler and commercial bovine gelatins appeared to be associated with differences in their amino acid composition and molecular weight distribution. The sensory evaluation results revealed that broiler skin gelatin could be a potential alternative to commercial bovine gelatin, useful in various food products.


Asunto(s)
Proteínas Aviares/química , Pollos , Gelatina/química , Piel/química , Animales , Proteínas Aviares/aislamiento & purificación , Bovinos , Gelatina/aislamiento & purificación
3.
Benef Microbes ; 4(3): 237-45, 2013 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-23887032

RESUMEN

Adhesion to oral soft and hard tissue is crucial for bacterial colonisation in the mouth. The aim of this work was to select strains of oral lactic acid bacteria that could be used as probiotics for oral health. To this end, the adhesive properties of some lactic acid bacteria were investigated. Seventeen lactic acid bacteria including two Streptococcus mutans strains were isolated from the oral cavity of healthy children, while other strains were isolated from fermented meat products. The bacterial strains were applied to teeth surfaces covered with saliva or without saliva. A significant diversity in adhesion capacity to teeth surfaces among the lactic acid bacteria was observed. Lactic acid bacteria isolated from the oral cavity adhered the best to teeth surfaces covered with saliva, whereas lactic acid bacteria isolated from fermented meat samples adhered the best to tooth surface without saliva. All strains of lactic acid bacteria were able to reduce the number of S. mutans cells, in particular on saliva-coated tooth surface. Therefore, they might have potential as probiotics for the oral cavity.


Asunto(s)
Adhesión Bacteriana , Enterococcus/fisiología , Lactobacillus/fisiología , Carne/microbiología , Boca/microbiología , Streptococcus mutans/fisiología , Niño , Enterococcus/aislamiento & purificación , Humanos , Lactobacillus/aislamiento & purificación , Probióticos/aislamiento & purificación , Saliva/microbiología , Streptococcus mutans/aislamiento & purificación , Diente/microbiología
4.
Clin Microbiol Infect ; 15(10): 943-6, 2009 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-19548920

RESUMEN

In the present study, the incidence and antimicrobial resistance patterns of the microorganisms that caused bloodstream infections (BSIs) in a medical-surgical intensive care unit during the years 2005-2007 were determined. The mean BSI incidence density was 6.56 per 1000 patient-days. The incidence density increased linearly during the study period (from 3.57 to 9.60 per 1000 patient-days). Staphylococcus aureus was most frequently isolated (47.3%), followed by Enterococcus spp. (10.8%) and Candida spp. (10.1%). There was a high rate of resistance to several of the prescribed antimicrobials among the bacteria isolated from patients with BSIs.


Asunto(s)
Bacteriemia/microbiología , Infecciones Bacterianas/microbiología , Fungemia/microbiología , Hongos/clasificación , Bacterias Gramnegativas/clasificación , Bacterias Grampositivas/clasificación , Micosis/microbiología , Bacteriemia/epidemiología , Infecciones Bacterianas/epidemiología , Farmacorresistencia Bacteriana , Fungemia/epidemiología , Hongos/efectos de los fármacos , Hongos/aislamiento & purificación , Bacterias Gramnegativas/efectos de los fármacos , Bacterias Gramnegativas/aislamiento & purificación , Bacterias Grampositivas/efectos de los fármacos , Bacterias Grampositivas/aislamiento & purificación , Humanos , Incidencia , Unidades de Cuidados Intensivos , Pruebas de Sensibilidad Microbiana , Micosis/epidemiología
5.
Int J Dent Hyg ; 7(2): 90-5, 2009 May.
Artículo en Inglés | MEDLINE | ID: mdl-19422147

RESUMEN

Osteonecrosis means the process of bone death. Bisphosphonates (BPs) are becoming recognized increasingly as having a significant impact on dental treatments. BPs are the most widely used class of anti-resorptive drugs. They prevent bone resorption through osteoclast inhibition and are considered the standard of care for the management of metastatic bone disease. BPs are used for the treatment of skeletal disorders such as osteoporosis, hypercalcaemia of malignancy, osteolytic lesions arising from solid tumours and Paget's disease, breast cancer or prostate cancer. Jaw necrosis appears to be associated with the intravenous (i.v.) use of BPs. The aim of this review paper is to update the understanding of healthcare professionals to the osteonecrosis of jaws, mechanism of action and classification of BPs, management of the patients with BP-related osteonecrosis (BRON) of the jaws. An interdisciplinary approach has been emphasized to prevent and manage the condition. Finally, the role of dental practitioners including dental hygienists has been discussed to early diagnose the BRON and improve the quality of life of patients with the condition.


Asunto(s)
Conservadores de la Densidad Ósea/efectos adversos , Difosfonatos/efectos adversos , Enfermedades Maxilomandibulares/inducido químicamente , Osteonecrosis/inducido químicamente , Grupo de Atención al Paciente , Conservadores de la Densidad Ósea/administración & dosificación , Conservadores de la Densidad Ósea/farmacología , Enfermedades Óseas/tratamiento farmacológico , Neoplasias Óseas/tratamiento farmacológico , Neoplasias Óseas/secundario , Higienistas Dentales , Odontólogos , Difosfonatos/administración & dosificación , Difosfonatos/farmacología , Humanos , Inyecciones Intravenosas , Enfermedades Maxilomandibulares/prevención & control , Osteoclastos/efectos de los fármacos , Osteonecrosis/prevención & control
6.
Eur J Anaesthesiol ; 25(10): 816-20, 2008 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-18400140

RESUMEN

BACKGROUND AND OBJECTIVE: The anaesthetic method for intracranial neurosurgery must provide haemodynamic stability on emergence and allow early evaluation of the neurological status. In this study, we examined the effects of the alpha-2 agonist dexmedetomidine given at the end of the procedure to prevent hyperdynamic responses during extubation and to allow a comfortable and high-quality recovery. METHODS: Forty ASA I-III patients, aged between 18 and 75 yr, having elective intracranial surgery, were divided into two random groups. Standard procedures and drugs were used for monitoring, induction and maintenance. Isoflurane was reduced by 50% 5 min before the end of the surgery, and in Group I dexmedetomidine 0.5 microg kg(-1) and in Group II 20 mL of 0.9% NaCl were administrated intravenously over 60 s. Systolic, diastolic and mean arterial pressures, and heart rate were recorded before intravenous administration and also at 1, 3 and 5 min after administration, 1 min before extubation, during extubation, 1, 3, 5, 10, 15, 20 and 30 min after extubation. Duration of extubation and recovery were noted, and the quality of extubation was evaluated on a 5-point scale. RESULTS: Mean arterial pressure and heart rate were significantly higher in Group II than in Group I (P < 0.01). There were no statistically significant differences between groups regarding the duration of extubation and recovery (P > 0.05). Extubation quality score of all the patients were 1 in Group I and in Group II, the quality scores were 1 for 35%, 2 for 45% and 3 for 20% of the patients (P < 0.001). None of the patients in Group I and Group II showed respiratory depression, nausea or vomiting. CONCLUSION: Without interfering in recovery time, dexmedetomidine 0.5 microg kg(-1) administered 5 min before the end of surgery stabilizes haemodynamics, allows easy extubation, provides a more comfortable recovery and early neurological examination following intracranial operations.


Asunto(s)
Periodo de Recuperación de la Anestesia , Encefalopatías/cirugía , Dexmedetomidina/farmacología , Frecuencia Cardíaca/efectos de los fármacos , Recuperación de la Función/efectos de los fármacos , Adolescente , Adulto , Anciano , Presión Sanguínea/efectos de los fármacos , Femenino , Humanos , Intubación , Masculino , Persona de Mediana Edad , Neurocirugia
8.
Am J Physiol Lung Cell Mol Physiol ; 278(5): L1039-44, 2000 May.
Artículo en Inglés | MEDLINE | ID: mdl-10781436

RESUMEN

The antiarrhythmic amiodarone (AM) and its metabolite desethylamiodarone (Des) are known to cause AM-induced pulmonary toxicity, but the mechanisms underlying this disorder remain unclear. We hypothesized that AM might cause AM-induced pulmonary toxicity in part through the induction of apoptosis or necrosis in alveolar epithelial cells (AECs). Two models of type II pneumocytes, the human AEC-derived A549 cell line and primary AECs isolated from adult Wistar rats, were incubated with AM or Des for 20 h. Apoptotic cells were determined by morphological assessment of nuclear fragmentation with propidium iodide on ethanol-fixed cells. Necrotic cells were quantitated by loss of dye exclusion. Both AM and Des caused dose-dependent necrosis starting at 2.5 and 0.1 microg/ml, respectively, in primary rat AECs and at 10 and 5 microg/ml in subconfluent A549 cells (P < 0.05 and P < 0.01, respectively). AM and Des also induced dose-dependent apoptosis beginning at 2.5 microg/ml in the primary AECs (P < 0.05 for both compounds) and at 10 and 5 microg/ml, respectively, in the A549 cell line (P < 0.01). The two compounds also caused significant net cell loss (up to 80% over 20 h of incubation) by either cell type at drug concentrations near or below the therapeutic serum concentration for AM. The cell loss was not due to detachment but was blocked by the broad-spectrum caspase inhibitor Z-Val-Ala-Asp-fluoromethylketone. Furthermore, the angiotensin-converting enzyme inhibitor captopril (500 ng/ml) and the angiotensin-receptor antagonist saralasin (50 microg/ml) significantly inhibited both the induction of apoptosis and net cell loss in response to AM. These results are consistent with recent work from this laboratory demonstrating potent inhibition of apoptosis in human AECs by captopril (Uhal BD, Gidea C, Bargout R, Bifero A, Ibarra-Sunga O, Papp M, Flynn K, and Filippatos G. Am J Physiol Lung Cell Mol Physiol 275: L1013-L1017, 1998). They also suggested that the accumulation of AM and/or its primary metabolite Des in lung tissue may induce cytotoxicity of AECs that might be inhibitable by angiotensin-converting enzyme inhibitors or other antagonists of the renin-angiotensin system.


Asunto(s)
Amiodarona/análogos & derivados , Apoptosis/efectos de los fármacos , Inhibidores Enzimáticos/farmacología , Células Epiteliales/citología , Alveolos Pulmonares/citología , Adenocarcinoma , Clorometilcetonas de Aminoácidos/farmacología , Amiodarona/farmacología , Inhibidores de la Enzima Convertidora de Angiotensina/farmacología , Animales , Captopril/farmacología , Inhibidores de Cisteína Proteinasa/farmacología , Citotoxinas/farmacología , Relación Dosis-Respuesta a Droga , Células Epiteliales/efectos de los fármacos , Humanos , Técnicas In Vitro , Neoplasias Pulmonares , Masculino , Ratas , Ratas Wistar , Sistema Renina-Angiotensina/fisiología , Células Tumorales Cultivadas
9.
N Y State Dent J ; 58(2): 51-2, 1992 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-1565326

RESUMEN

The "Big Blue" van of The Children's Aid Society brings much needed health services to homeless and underserved children of New York City.


Asunto(s)
Servicios de Salud del Niño , Servicios de Salud Dental , Indigencia Médica , Unidades Móviles de Salud , Niño , Diseño de Equipo , Humanos , Área sin Atención Médica , New York
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA